Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Agnew

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Bioconjugate Chemistry|November 25, 2014
Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imagingBrian M Zeglis, Charles B Davis, Dalya Abdel-Atti, et al.
Bioconjugate Chemistry|July 1, 2016
Pretargeted PET Imaging Using a Site-Specifically Labeled ImmunoconjugateBrendon E Cook, Pierre Adumeau, Rosemery Membreno, et al.
Electrophoresis|September 29, 2009
A novel approach to tag and identify geranylgeranylated proteinsLai N Chan, Courtenay Hart, Lea Guo, et al.
Proteomics|April 28, 2015
Bioorthogonal mimetics of palmitoyl-CoA and myristoyl-CoA and their subsequent isolation by click chemistry and characterization by mass spectrometry reveal novel acylated host-proteins modified by HIV-1 infectionDavid R Colquhoun, Alexey E Lyashkov, Ceereena Ubaida Mohien, et al.
Journal of the American Chemical Society|August 8, 2008
Direct in-gel fluorescence detection and cellular imaging of O-GlcNAc-modified proteinsPeter M Clark, Jessica F Dweck, Daniel E Mason, et al.
Proteomics|July 23, 2003
Global quantitative phosphoprotein analysis using Multiplexed Proteomics technologyThomas H Steinberg, Brian J Agnew, Kyle R Gee, et al.
Journal of Lipid Research|September 2, 2008
Increasing the length of progerin's isoprenyl anchor does not worsen bone disease or survival in mice with Hutchinson-Gilford progeria syndromeBrandon S J Davies, Shao H Yang, Emily Farber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 25, 2024
First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast CancerRandy Yeh, Joseph A O'Donoghue, Vetri Sudar Jayaprakasam, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Bioconjugate Chemistry|November 25, 2014
Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imagingBrian M Zeglis, Charles B Davis, Dalya Abdel-Atti, et al.
Bioconjugate Chemistry|July 1, 2016
Pretargeted PET Imaging Using a Site-Specifically Labeled ImmunoconjugateBrendon E Cook, Pierre Adumeau, Rosemery Membreno, et al.
Electrophoresis|September 29, 2009
A novel approach to tag and identify geranylgeranylated proteinsLai N Chan, Courtenay Hart, Lea Guo, et al.
Proteomics|April 28, 2015
Bioorthogonal mimetics of palmitoyl-CoA and myristoyl-CoA and their subsequent isolation by click chemistry and characterization by mass spectrometry reveal novel acylated host-proteins modified by HIV-1 infectionDavid R Colquhoun, Alexey E Lyashkov, Ceereena Ubaida Mohien, et al.
Journal of the American Chemical Society|August 8, 2008
Direct in-gel fluorescence detection and cellular imaging of O-GlcNAc-modified proteinsPeter M Clark, Jessica F Dweck, Daniel E Mason, et al.
Proteomics|July 23, 2003
Global quantitative phosphoprotein analysis using Multiplexed Proteomics technologyThomas H Steinberg, Brian J Agnew, Kyle R Gee, et al.
Journal of Lipid Research|September 2, 2008
Increasing the length of progerin's isoprenyl anchor does not worsen bone disease or survival in mice with Hutchinson-Gilford progeria syndromeBrandon S J Davies, Shao H Yang, Emily Farber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 25, 2024
First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast CancerRandy Yeh, Joseph A O'Donoghue, Vetri Sudar Jayaprakasam, et al.
Pageof 2